BioValues (@BioValues) profile picture

Biotech investor. Tend to focus on contrarian names, so I'm probably buying what you are selling/hating on. All tweets are my opinions only.

Denver
Joined June 2010
$XBI final stand around support here
716
$ACET now at $2.40 or $22M market cap vs $100M Sept cash. Going to be real interesting what RA and Orbimed decide to do here. Outside of Lupus, got some potentially desirable early stage in-vivo CAR-T programs
1
5
1,304
$PEPG definitely feels like something big coming. And some interesting recent job postings too. Dec 4th below:
2
1
9
3,545
$NKTX preparing for registrational trials:
1
1
8
2,213
$ENGN looks like positive news coming next week regarding 12 month data and FDA alignment for BLA. Posted VP of Marketing position for commercial launch:
2
1
6
3,367
Replying to @UpnDownisBack
bodes well
1
1
81
$nktx $3/share in cash going into first ever CAR-NK data this weekend:
2
1
10
1,870
$LYEL yesterday sold for largest $ gain ever after buying in Oct. Used proceeds to re-buy crushed $ACET at $27M MC, crushed $CATX under $1 and add $NKTX (data this weekend), $PEPG (data likely Monday), and $ENGN (data any moment now). Still holding lotto $BCAB for strategic news
2
5
1,986
$PEPG presenting Tues Nov 10th at Gugg and Thur Nov 12th at Stifel. Imagine we get data next week, or Monday the 9th. Bodes well they plan on attending post data?
2
1
9
2,813
$ENGN anyone follow name? Company posted a new commercial job 4 days ago. Should have updated 12 month data and FDA BLA update any day now correct?
2
9
2,269
$bcab Tungsten is involved with BCAB currently and were the same folks involved in today's $BOLT merger
1,046